Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single Virus Detection Techniques Diagnoses Diseases Faster

By LabMedica International staff writers
Posted on 20 Jun 2013
Optics-based methods have been developed for determining the exact viral load of a sample by counting individual virus particles.

The viral load is a measurement of the severity of a viral infection, and helps clinicians try to gauge how many viruses are packed into a certain volume of blood or other bodily fluid. More...


Two groups of scientists and engineers at the University of California campuses in Los Angles (UCLA; CA, USA) and Santa Cruz (UCSC; CA, USA) collaborated to develop methods that are faster and cheaper than standard tests and they offer the potential to conduct the measurements in a medical office or hospital instead of a laboratory. The bioengineers at UCLA are working to directly image single virus particles using holographic microscopy, while the team at UCSC is detecting single particles tagged with fluorescent labels on a microfluidic chip.

The UCLA team has demonstrated the ability to capture optical images of single viruses and nanoparticles over a comparatively large field of view using nanolenses that self-assemble around the virus particles like little magnifying glasses. This wide field of view allows the device to form images of many nanoparticles in a single photograph and provides a high-throughput platform for a direct and accurate viral load count. The instrument can be made sufficiently compact and lightweight for field applications and, attached to a cell phone, could become useful even in remote locations.

The UCSC team counts the viruses by detecting their nucleic acids, which is the genetic makeup of the viruses. The nucleic acids are labeled with a fluorescent dye, and light from the fluorescence is detected as they pass through a channel in a microfluidic chip about the size of a thumbnail. The labeling technique would allow clinicians to target specific viruses while ignoring unlabeled background material. This makes the process potentially useful in situations where clinicians already know what they are looking for, which is often the case for viral load tests.

Aydogan Ozcan, PhD, the lead scientist from UCLA, said, “Because viruses are very small compared to the wavelength of light, conventional light microscopy has difficulty producing an image due to weak scattering of subwavelength particles.” The team's new nanolens-nanoparticle assembly projects a hologram that can be recorded using a complementary metal-oxide-semiconductor (CMOS) imager chip, and digitally reconstructed to form an optical image of the particle. The study was presented at the Conference on Lasers and Electro-Optics held June 9–14, 2013, in San Jose (CA, USA).

Related Links:

University of California Los Angeles
University of California Santa Cruz



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.